Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
08/09/2012
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Principles of method if other than guideline:
The acute oral toxicity study of Solvent blue-43 was conducted in wistar albino rats. The study was conducted under the OECD Guideline-423 for testing of chemicals following Good Laboratory Practice. The healthy wistar albino rats of body weight 200±20 gm were selected for study after acclimatization to standard laboratory condition for period of one week.
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
disodium 4-{[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium 3-{[ethyl({4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}cyclohexa-2,5-dien-1-ylidene)(2-sulfonatophenyl)methyl]phenyl})amino]methyl}benzene-1-sulfonate
Cas Number:
61813-75-0
Molecular formula:
C61H70N6S3O9
IUPAC Name:
disodium 4-{[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium 3-{[ethyl({4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}cyclohexa-2,5-dien-1-ylidene)(2-sulfonatophenyl)methyl]phenyl})amino]methyl}benzene-1-sulfonate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report) : Solvent Blue 43
- Molecular formula (if other than submission substance): C61H70N6S3O9
- Molecular weight (if other than submission substance): 1136
- Substance type : solid
- Physical state : powder
- Analytical purity : 99.55

Test animals

Species:
rat
Strain:
Wistar
Sex:
female

Administration / exposure

Route of administration:
oral: drinking water
Vehicle:
unchanged (no vehicle)
Doses:
The test was administered by oral route by using of oral cannula at the dose volume of 10 ml/kg b.wt.
No. of animals per sex per dose:
3

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
5 000 mg/kg bw
Based on:
test mat.

Any other information on results incl. tables

Starting dose 300 mg/kg body weight:

Step- I:

The test compound was dissolved in distilled water and administered orally at the dose level of 300 mg/kg body weight (dose volume 10ml/kg) to three female rats. Whereas, vehicle control group treated with the distilled water at the dose level of 10 ml/kg b.wt. The treated animals were closely observed for clinical signs of intoxication during first four hours of test compound administration. Thereafter, all the animals were observed periodically at one hour interval for 24 hrs and once daily for a period of 14 days. The necropsy was performed on all animals which died during the study or were sacrificed at termination of the study.

The test compound administered at the dose level of 300 mg/kg b.wt did not produce any mortality throughout the period of observation 14 days. Furthermore, test compound solvent blue-43 did not elicit any clinical signs of intoxication throughout the period of observation. No clinical signs were observed in vehicle control group.

The necropsy finding did not show any gross pathological changes in animal which was sacrifice during the end of experimentation.

 

 

Step -II:

After 72 hrs, the result of step-I was confirmed by administration of same dose level (300 mg/kg. b.wt) of test compound in additional three animals of same sex (OECD-423 guidelines).

The test compound administered at the dose level of 300 mg/kg b.wt did not produce any mortality throughout the period of observation 14 days. Furthermore, test compound solvent blue-43 did not elicit any clinical signs of intoxication throughout the period of observation. No clinical signs were observed in vehicle control group.

The necropsy finding did not show any gross pathological changes in animal which was sacrificed during the end of experimentation.

Final dose 2000 mg/kg body weight:

Step-I

The test compound was dissolved in distilled water and administered orally at the dose level of 2000 mg/kg body wt. (dose volume 10 ml/kg) to three female rats. All the animals were closely observed for clinical sign of toxicity and mortality gross pathological changes individually once in 30 minutes, 1, 2, 4 and 6 hrs intervals during the first 24 hrs and thereafter, once daily for a period of 14 days. The necropsy was performed on all animals which died during the study or were sacrificed at termination of the study.

The necropsy was performed on all animals which died during the study or were sacrificed at termination of the study.

The test compound administered at the dose level of 2000 mg/kg b.wt did not produce any mortality throughout the period of observation 14 days. Furthermore, test compound solvent blue-43 did not elicit any clinical signs of intoxication throughout the period of observation.

The necropsy finding did not show any gross pathological changes in animal which was sacrifice during the end of experimentation.

Step -II:

After 72 hrs, the result of step-I was confirmed by administration of same dose level (2000 mg/kg. b.wt) of test compound in additional three animals of same sex (OECD-423 guidelines).

The test compound administered at the dose level of 2000 mg/kg b.wt did not produce any mortality throughout the period of observation 14 days. Furthermore, test compound solvent blue-43 did not elicit any clinical signs of intoxication throughout the period of observation. No clinical signs were observed in vehicle control group.

The necropsy finding did not show any gross pathological

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
It is concluded that the test compound Solvent blue-43 sponsored by Unique Chemicals & Allied Products following the guideline OECD-423 is acutely nontoxic to wistar albino rats.
Executive summary:

Finally, it is concluded that the test compound Solvent blue-43 following the guideline OECD-423 is acutely nontoxic to wistar albino rats. According toGlobally Harmonized Classification System for Chemical Substances, it comes under the Globally Harmonized Classification (GHC) Category-5and LD50cutoff is 5000 mg/kg b.wt.